Mastodon

Hexosept-Rn (Suppositories) Instructions for Use

Marketing Authorization Holder

Rubicon, LLC (Republic of Belarus)

ATC Code

G01AX (Other antimicrobial drugs and antiseptics)

Active Substance

Chlorhexidine (Rec.INN registered by WHO)

Dosage Form

Bottle OTC Icon Hexosept-Rn Vaginal suppositories 16 mg: 10 pcs.

Dosage Form, Packaging, and Composition

Vaginal suppositories white or yellowish-white in color, torpedo-shaped; a funnel-shaped depression is allowed; an air core may be present on the longitudinal section.

1 supp.
Chlorhexidine digluconate 16 mg,
   Which corresponds to the content of a 20% chlorhexidine digluconate solution 85.2 mg

Excipients : macrogol 1000 (polyethylene oxide 1000) – up to 3100 mg.

5 pcs. – contour cell packs (2) – cardboard boxes.

Clinical-Pharmacological Group

Topical antiseptic for use in gynecology

Pharmacotherapeutic Group

Antiseptic

Pharmacological Action

Antiseptic agent. Chlorhexidine exhibits bactericidal action (against gram-positive and gram-negative bacteria) – at a temperature of 22°C (71.6°F) and exposure for 1 min; fungicidal action at a temperature of 22°C (71.6°F) and exposure for 10 min; virucidal action (against lipophilic viruses).

It acts on bacterial spores only at elevated temperatures. It is stable, and after skin treatment, it remains on it in a certain amount sufficient to manifest a bactericidal effect. It retains activity (although somewhat reduced) in the presence of blood, pus, various secretions, and organic substances.

It does not have a damaging effect on items made of glass, plastic, and metals.

Pharmacokinetics

When applied externally and locally, it is not absorbed into the systemic circulation and does not have a systemic effect.

Indications

Trichomonal colpitis, cervical erosion, vulvar itching, prevention of venereal diseases (including gonorrhea, syphilis, trichomoniasis, chlamydia, ureaplasmosis); prevention of infectious and inflammatory complications in obstetrics and gynecology (before surgical treatment of gynecological diseases, before childbirth, abortion, before and after insertion of an IUD, before and after diathermocoagulation of the cervix, before intrauterine examinations); treatment of bacterial vaginosis, colpitis (including nonspecific, mixed, trichomonal).

ICD codes

ICD-10 code Indication
A59 Trichomoniasis
L29.2 Pruritus vulvae
N72 Inflammatory disease of cervix uteri (including cervicitis, endocervicitis, exocervicitis)
N76 Other inflammatory diseases of vagina and vulva
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
N86 Erosion and ectropion of cervix
N89.8 Other noninflammatory disorders of vagina
Z29.8 Other specified prophylactic measures
Z51.4 Preparatory procedures for subsequent treatment or examination, not elsewhere classified
ICD-11 code Indication
1A92 Trichomoniasis
1F23.10 Candidiasis of vulva and vagina
1F65 Enterobiasis
1H0Z Unspecified infection
GA00 Vulvitis
GA02.Z Unspecified vaginitis
GA0Z Inflammatory diseases of female genital tract, unspecified
GA15.1 Erosion or ectropion of cervix
GA42.0 Pruritus vulvae
GC42.1 Painful intercourse
MF3A Vaginal discharge
QB9A Preparatory procedures for subsequent treatment
QC05.Z Prophylactic measures, unspecified
1A94.0 Genital or urogenital tract infection caused by Herpes simplex virus
GA41 Ulcerative or erosive diseases of vulva
GA0Z Inflammatory diseases of female genital tract, unspecified
XA5WW1 Cervix uteri
GA1Z Unspecified noninflammatory disorders of female genital tract
XA1LK7 Vagina

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

For treatment of infectious and inflammatory diseases (trichomonal colpitis, bacterial vaginosis, nonspecific colpitis), administer one 16 mg vaginal suppository twice daily, for 7 to 10 days.

For prevention of infectious complications before gynecological surgery, childbirth, abortion, IUD insertion, or diathermocoagulation, administer one suppository twice daily for 5 to 7 days prior to the procedure.

For post-interventional care, administer one suppository twice daily for 5 to 7 days following the procedure.

For prevention of venereal diseases, administer one suppository as soon as possible, but no later than two hours after sexual intercourse.

Thoroughly wash hands before and after administration. Insert the suppository deeply into the vagina while lying on your back with knees bent.

For optimal efficacy, complete the full prescribed course of treatment, even if symptoms improve earlier.

Discontinue use immediately and consult a physician if bloody vaginal discharge, severe itching, rash, or burning occurs.

Adverse Reactions

Allergic reactions: skin rash, itching, severe allergic reactions, including anaphylaxis.

Skin and subcutaneous tissue disorders: dry skin, itching, dermatitis, photosensitivity.

Local reactions: enamel staining, tartar deposition, taste disturbance.

With vaginal use allergic reactions (rash, itching), burning are possible; very rarely – anaphylactic reactions; in some cases – bloody discharge from the vagina.

Contraindications

Hypersensitivity to chlorhexidine.

Use in Pregnancy and Lactation

If it is necessary to use during pregnancy and breastfeeding, the expected benefit of therapy for the mother and the possible risk to the fetus should be weighed.

Pediatric Use

Use with caution in children.

Geriatric Use

There are currently no restrictions for use in elderly patients.

Special Precautions

With intravaginal use, in case of bloody discharge from the vagina, the use of chlorhexidine should be discontinued.

Avoid getting chlorhexidine into the eyes (except for a special dosage form intended for use in ophthalmology), as well as contact with the meninges and the auditory nerve.

Drug Interactions

It is used in a neutral environment; at pH 5-8 the difference in activity is small; at pH above 8, a precipitate forms.

It is not used in combination with anionic compounds, including soap.

It is incompatible with carbonates, chlorides, phosphates, borates, sulfates, and citrates.

The use of hard water reduces bactericidal properties.

It is compatible with medicinal products containing a cationic group (benzalkonium chloride, cetrimonium bromide).

Storage Conditions

Store at 2°C (36°F) to 15°C (59°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS